Overview
Myelokathexis refers to the abnormal retention of neutrophils in the bone marrow due to impaired release, often associated with hypogammaglobulinemia and specific immune complex interactions impacting IgG subclass levels 2.Diagnosis
Elevated neutrophil counts in peripheral blood
Low levels of specific IgG subclasses (IgG1, IgG2, IgG4) 2
Evidence of immune complex formation involving IgM and IgG 2
Assessment of immunoglobulin turnover rates and subclass distribution 2Management
Intravenous immunoglobulin (IVIG) therapy for hypogammaglobulinemia 1
Specific management of underlying conditions like Sjögren's syndrome and cryoglobulinemia 2Special Populations
Pregnancy: IVIG can effectively transfer IgG subclasses to the fetus 1
Comorbidities: Consider immune complex-related complications in Sjögren's syndrome and manage accordingly 2Key Recommendations
Use intravenous immunoglobulin therapy to manage hypogammaglobulinemia and facilitate subclass transfer during pregnancy (Evidence: Moderate 1)
Evaluate and manage underlying immune complex disorders, such as those involving specific IgM-IgG interactions, to address shortened IgG subclass survival (Evidence: Weak 2)
Monitor immunoglobulin turnover and subclass levels in patients with suspected myelokathexis to guide treatment adjustments (Evidence: Expert opinion 2)References
1 Smith CI, Hammarström L. Intravenous immunoglobulin in pregnancy. Obstetrics and gynecology 1985. link
2 Waldmann TA, Johnson JS, Talal N. Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgM. The Journal of clinical investigation 1971. link